These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24696262)

  • 1. Clinical significance of serum tenascin-C levels in breast cancer.
    Tastekin D; Tas F; Karabulut S; Duranyildiz D; Serilmez M; Guveli M; Vatansever S
    Tumour Biol; 2014 Jul; 35(7):6619-25. PubMed ID: 24696262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of serum tenascin-c levels in epithelial ovarian cancer.
    Didem T; Faruk T; Senem K; Derya D; Murat S; Murat G; Oznur K
    Tumour Biol; 2014 Jul; 35(7):6777-82. PubMed ID: 24722824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin C is a prognostic determinant and potential cancer-associated fibroblasts marker for breast ductal carcinoma.
    Yang Z; Ni W; Cui C; Fang L; Xuan Y
    Exp Mol Pathol; 2017 Apr; 102(2):262-267. PubMed ID: 28223108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenascin-W, a new marker of cancer stroma, is elevated in sera of colon and breast cancer patients.
    Degen M; Brellier F; Schenk S; Driscoll R; Zaman K; Stupp R; Tornillo L; Terracciano L; Chiquet-Ehrismann R; Rüegg C; Seelentag W
    Int J Cancer; 2008 Jun; 122(11):2454-61. PubMed ID: 18306355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.
    Gebauer F; Gelis S; Zander H; Meyer KF; Wolters-Eisfeld G; Izbicki JR; Bockhorn M; Tachezy M
    Oncotarget; 2016 Apr; 7(15):20945-52. PubMed ID: 26967391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer.
    Ni WD; Yang ZT; Cui CA; Cui Y; Fang LY; Xuan YH
    Biochem Biophys Res Commun; 2017 May; 486(3):607-612. PubMed ID: 28341124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serum tenascin C level is a marker of metabolic disorder-related inflammation affecting pancreatic cancer prognosis.
    Sato K; Hikita H; Shigekawa M; Soma K; Yamauchi R; Sung J; Kato S; Sasaki Y; Kudo S; Fukumoto K; Shirai K; Murai K; Tahata Y; Yoshioka T; Nishio A; Saito Y; Kodama T; Sasaki Y; Tatsumi T; Takehara T
    Sci Rep; 2024 May; 14(1):12028. PubMed ID: 38797735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer.
    Karabulut S; Tas F; Tastekin D; Karabulut M; Yasasever CT; Ciftci R; Güveli M; Fayda M; Vatansever S; Serilmez M; Disci R; Aydıner A
    Tumour Biol; 2014 Sep; 35(9):8849-60. PubMed ID: 24891186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Tenascin-C and Twist1 in gastric cancer: cancer progression and prognosis.
    Qi W; Yang Z; Li H; Cui Y; Xuan Y
    APMIS; 2019 Feb; 127(2):64-71. PubMed ID: 30698309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenascin-C expression is significantly associated with the progression and prognosis in gastric GISTs.
    Shen C; Wang C; Yin Y; Chen H; Yin X; Cai Z; Chen Z; Zhang B; Zhou Z
    Medicine (Baltimore); 2019 Jan; 98(2):e14045. PubMed ID: 30633201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.
    Banys-Paluchowski M; Fehm T; Janni W; Aktas B; Fasching PA; Kasimir-Bauer S; Milde-Langosch K; Pantel K; Rack B; Riethdorf S; Solomayer EF; Witzel I; Müller V
    BMC Cancer; 2018 May; 18(1):541. PubMed ID: 29739347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between coronary artery calcium score and serum tenascin-C level in patients without known coronary artery disease.
    Ozmen Yildiz P; Yildiz I; Ozmen C; Karabacak M; Doven O
    Acta Cardiol; 2015 Dec; 70(6):633-9. PubMed ID: 26717210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
    Závada J; Uher M; Svobodová R; Olejárová M; Hušáková M; Ciferská H; Hulejová H; Tomčík M; Šenolt L; Vencovský J
    Arthritis Res Ther; 2015 Nov; 17():341. PubMed ID: 26608564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum tenascin-C: a novel biomarker for diagnosis and predicting prognosis of rheumatic carditis?
    Karatas Z; Baysal T; Alp H; Toker A
    J Trop Pediatr; 2013 Dec; 59(6):476-82. PubMed ID: 23868575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression of E-selectin in tissue and its protein level in serum of breast cancer patients.
    Shaker OG; Ay El-Deen MA; Abd El-Rahim MT; Talaat RM
    Tumori; 2006; 92(6):524-30. PubMed ID: 17260494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of transforming growth factor beta1 in patients with breast cancer.
    Sheen-Chen SM; Chen HS; Sheen CW; Eng HL; Chen WJ
    Arch Surg; 2001 Aug; 136(8):937-40. PubMed ID: 11485532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenascin-C as a prognostic determinant of colorectal cancer through induction of epithelial-to-mesenchymal transition and proliferation.
    Yang Z; Zhang C; Qi W; Cui C; Cui Y; Xuan Y
    Exp Mol Pathol; 2018 Oct; 105(2):216-222. PubMed ID: 30170017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L1 Cell Adhesion Molecule and Its Soluble Form sL1 Exhibit Poor Prognosis in Primary Breast Cancer Patients.
    Wu JD; Hong CQ; Huang WH; Wei XL; Zhang F; Zhuang YX; Zhang YQ; Zhang GJ
    Clin Breast Cancer; 2018 Oct; 18(5):e851-e861. PubMed ID: 29510897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of serum epidermal growth factor receptor (EGFR) levels in patients with breast cancer.
    Tas F; Bilgin E; Karabulut S; Duranyildiz D
    Cytokine; 2015 Jan; 71(1):66-70. PubMed ID: 25259789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine tenascin‑C is an independent risk factor for bladder cancer patients.
    Guan Z; Zeng J; Wang Z; Xie H; Lv C; Ma Z; Xu S; Wang X; He D; Li L
    Mol Med Rep; 2014 Mar; 9(3):961-6. PubMed ID: 24366195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.